With ‘hundreds’ of facilities audited over schizophrenia, CMS pursues harsher antipsychotics stance
By
Kimberly Marselas
Jan 19, 2024
With half of nursing homes audited in a new process admitting to misdiagnosing schizophrenia patients, the Centers for Medicare & Medicaid Services is extending its drive to reduce the use of certain drugs...
GAO chides CMS over delayed nursing home reporting, antipsychotic transparency
By
Kimberly Marselas
Jun 23, 2023
Some Care Compare information on nursing homes is too old and some is too hard to understand, reported a government watchdog.
Audits trigger new concern over aging CMS antipsychotic standards
By
Kimberly Marselas
May 03, 2023
Worries over federal audits designed to monitor nursing homes for inappropriate schizophrenia diagnosing continued to mount as some providers learned they had “failed” their check-ups months into the...
Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
As antipsychotic use appears to backslide among nursing home residents, risks mount
By
Kimberly Marselas
Oct 11, 2021
For more than a decade, patient advocates and federal regulators have called for a reduction in nursing homes’ use of antipsychotic medications, a class of drugs once widely associated with controlling...